Dr. Anna Santoro | Biochemistry, Genetics and Molecular Biology | Research Excellence Award
Beth Israel Deaconess Medical Center | United States
Dr. Anna Santoro’s research profile reflects a strong and sustained contribution to biomedical and toxicological sciences, with a particular focus on inflammatory pathways, metabolic regulation, environmental toxicants, and neuroendocrine mechanisms. Her scholarly output comprises 28 peer-reviewed documents, which together have received 1,584 citations across 1,472 citing documents, demonstrating broad international impact and cross-disciplinary relevance. With an h-index of 22, her work shows both productivity and consistent citation performance. Key investigations explore the biological effects of non-dioxin-like polychlorinated biphenyls on cellular apoptosis, lipid metabolism, and endocrine signaling, alongside influential studies on palmitoylethanolamide and its protective roles in metabolic disorders, hypertension, renal injury, and neuroinflammation. Her publications in high-impact journals such as Toxicology Letters, Endocrinology, PLoS One, and Journal of Nutritional Biochemistry highlight rigorous experimental approaches and translational relevance, positioning her research as a significant reference point in toxicology, pharmacology, and metabolic disease research.
1200
800
400
0
1,584
22
Citations
h-index
Featured Publications
ATGL-catalyzed biosynthesis mediates the upregulation of FAHFA levels in white adipose tissue with fasting
– Journal of Biological Chemistry, 2026
Inflammation causes insulin resistance in mice via IRF3-mediated reduction in FAHFA levels
– Nature Communications, 2024
Adipocyte Regulation of Insulin Sensitivity and the Risk of Type 2 Diabetes
– New England Journal of Medicine, 2023
Insulin action in adipocytes, adipose remodeling, and systemic effects
– Cell Metabolism, 2021